These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34782254)

  • 1. [Cardiovascular risk management in type-2 diabetes: Is the patients' cardiovascular risk adequately considered in type-2 specialist diabetes care?].
    Brenner S; Daikeler R; Oberaigner W; Stummer H
    Z Evid Fortbild Qual Gesundhwes; 2021 Dec; 167():6-14. PubMed ID: 34782254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden.
    Karlsson SA; Eliasson B; Franzén S; Miftaraj M; Svensson AM; Andersson Sundell K
    BMJ Open Diabetes Res Care; 2019; 7(1):e000639. PubMed ID: 31114701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and cholesterol management in patients with cardiovascular events and/or type 2 diabetes in the Netherlands.
    Heintjes E; Kuiper J; Lucius B; Penning-van Beest F; Kutikova L; Liem A; Herings R
    Curr Med Res Opin; 2017 Jan; 33(1):91-100. PubMed ID: 27646783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Cardiovascular Pharmacotherapy Guideline Adherence and Risk Factor Control in Portuguese Community Pharmacy Patients.
    Fonseca A; Lima TM; Fernandez-Llimos F; Castel-Branco MM; Figueiredo IV
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study.
    Fürthauer J; Flamm M; Sönnichsen A
    BMC Fam Pract; 2013 Apr; 14():47. PubMed ID: 23557543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines.
    Varkevisser RDM; Birnie E; Vollenbrock CE; Mul D; van Dijk PR; van der Klauw MM; Veeze H; Wolffenbuttel BHR; Aanstoot HJ
    BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35858715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline Adherence and Associated Outcomes in the Treatment of Type 2 Diabetes Mellitus Patients With an Incident Cardiovascular Comorbidity: An Analysis Based on a Large German Claims Dataset.
    Gabler M; Picker N; Geier S; Ley L; Aberle J; Lehrke M; Martin S; Riedl M; Wilke T
    Diabetes Ther; 2021 Apr; 12(4):1209-1226. PubMed ID: 33710520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to clinical guidelines in management of diabetes and prevention of cardiovascular disease in Qatar.
    Issam Diab M; Julienne Johnson B; Hudson S
    Int J Clin Pharm; 2013 Feb; 35(1):101-12. PubMed ID: 23135835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait.
    Al-Taweel DM; Awad AI; Johnson BJ
    Int J Clin Pharm; 2013 Apr; 35(2):244-50. PubMed ID: 23254942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of low-density lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS).
    Blom DJ; Raal F; Amod A; Naidoo P; Lai YE;
    Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):15-23. PubMed ID: 30720848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of care and clinical inertia in the management of cardiovascular risk factors in patients with type 1 and type 2 diabetes: data from AMD annals.
    Da Porto A; Candido R; Rocca A; Manicardi V; Nicolucci A; Miranda C; Cimino E; Di Bartolo P; Di Cianni G; Russo G
    J Endocrinol Invest; 2024 Oct; 47(10):2595-2602. PubMed ID: 38436903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline adherence and health outcomes in diabetes mellitus type 2 patients: a cross-sectional study.
    Oude Wesselink SF; Lingsma HF; Robben PB; Mackenbach JP
    BMC Health Serv Res; 2015 Jan; 15():22. PubMed ID: 25608447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International ChoLesterol management Practice Study.
    Blom DJ; Santos RD; Daclin V; Mercier F; Ruiz AJ; Danchin N;
    Eur J Prev Cardiol; 2020 Sep; 27(13):1403-1411. PubMed ID: 31533447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid therapy in daily routine].
    Sonntag F; Schaefer JR; Gitt AK; Weizel A; Jannowitz C; Karmann B; Pittrow D; Bestehorn K
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2047-52. PubMed ID: 23023622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
    Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK
    JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.
    Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators
    Eur J Prev Cardiol; 2016 Dec; 23(18):2007-2018. PubMed ID: 27638542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.